Sun Pharmaceutical Industries Limited (SUNPHARMA) — Financial Results
· NSE
Neutral
📢 Key Event
Trading window closure announced for Q1 results period
💡 Investor Takeaway
Trading restrictions will limit share transactions until after Q1 results are released.
Sun Pharmaceutical announced that its trading window for share transactions will close on 1 July 2026 and remain closed until 48 hours after the unaudited Q1 results are declared, with the board meeting date to be communicated later.
About Sun Pharmaceutical Industries Limited (SUNPHARMA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹4,50,643.09 Cr
P/E: 41.3
ROE: 15.1%
ROCE: 20.3%
Recent Announcements from Sun Pharmaceutical Industries Limited
-
Announcement — 7 July 2026
Sun Pharmaceutical Industries Limited presented its FY26 investor outlook, highlighting Rs 582.2 Bn revenue, 27.1% EBITDA margin, and 18.8% net margin... -
share transfer — 6 July 2026
Sun Pharmaceutical Industries Limited received a confirmation certificate from MUFG Intime India Private Limited, its share transfer agent, confirming... -
Announcement — 20 June 2026
Sun Pharmaceutical announced it will acquire 100% of Innovcare Lifesciences Private Limited for approximately **₹271.2 crores** in cash, targeting com... -
Announcement — 14 June 2026
Sun Pharmaceutical announced that Independent Director Gautam Doshi was arrested, but the matter is unrelated to the company and no operational or boa... -
🔴 Corporate Action — 11 June 2026
Sun Pharmaceutical announced its 34th Annual General Meeting on 31 July 2026 and set 07 July 2026 as the record date for a final dividend of ₹5 per sh...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when SUNPHARMA files new disclosures
Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUNPHARMA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research